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Murine Gammaherpesvirus-68 Infection Causes
Multi-Organ Fibrosis and Alters Leukocyte Trafficking
in Interferon-g Receptor Knockout Mice
Bahram Ebrahimi, Bernadette M. Dutia,
David G. Brownstein, and Anthony A. Nash
From the Laboratory for Clinical and Molecular Virology,
Department of Veterinary Pathology, University of Edinburgh,
Edinburgh, United Kingdom
Murine gammaherpesvirus-68 (MHV-68) infection in
interferon-g receptor knockout mice (IFN-gR2/2) re-
sults in splenic fibrosis and excessive loss of spleno-
cytes. In our present study we found that MHV-68
infection in IFN-gR2/2 mice also resulted in fibrosis
and atrophy of the mediastinal lymph nodes, inter-
stitial pulmonary fibrosis and fibrotic changes in the
liver. Atrophy and cellular depletion of the spleen in
IFN-gR2/2 was not the result of increased cell death.
The loss of splenocytes in IFN-gR2/2 mice, which was
most evident on day 23 after infection, correlated
with an increase in the number of leukocytes in pe-
ripheral blood. At the peak of leukocytosis, on day 23
after infection, peripheral blood cells from infected
IFN-gR2/2 mice were unable to traffic through the
fibrosed spleens of IFN-gR2/2 mice but were able to
enter the spleens of wild-type mice. This indicates
that leukocytosis was in part the result of emigration
of cells from the spleen and their subsequent exclu-
sion of re-entry at the height of fibrosis. Significant
cytokine and chemokine changes were observed in
spleens of IFN-gR2/2 mice. IFN-g , tumor necrosis fac-
tor-a (TNF-a ), TNF-b , interleukin-1b (IL-1b), trans-
forming growth factor-b1 (TGF-b1), lymphotactin,
and MIP-1b were elevated on day 14 after infection
whereas chemokines IP-10 and MIG were signifi-
cantly reduced. These changes suggest a role for dys-
regulated cytokines and chemokines in severe organ-
specific fibrosis with implications for immune-
mediated fibrotic disorders. (Am J Pathol 2001,
158:2117–2125)
Murine gammaherpesvirus-68 (MHV-68) is a natural
pathogen of murid rodents and is closely related to gam-
maherpesviruses Kaposi’s sarcoma-associated herpes-
virus, herpesvirus saimiri, and Epstein-Barr virus (EBV).1
Infection of immunocompetent mice with MHV-68 via the
respiratory route results in a lytic infection of alveolar
epithelial cells and a latent infection in B cells.2–3 Out-
comes of the lytic phase of infection include a profound
splenomegaly coincident with an increase of latently in-
fected splenic B cells4 and an infectious mononucleosis-like
syndrome with an elevated Vb4 CD8 T cell population.5–6
Interferon-g is a key Th1 cytokine,7 and it has been
implicated in protective immune responses to several
herpes viruses.8–10 In herpes simplex virus-1 infection,
lack of IFN-g diminished the ability to clear the skin infection,
with a delayed-type hypersensitivity response,11,12 and in-
fection in IFN-gR2/2 mice with murine cytomegalovirus
caused chronic aortic inflammation with prolonged shed-
ding of infectious virus.13
IFN-g is produced at high levels during the acute
phase of MHV-68 infection,14 and diminished levels of
IFN-g have been associated with recrudescence of lytic
MHV-68 infection in lungs.15,16 However, an unexpected
outcome of MHV-68 infection in IFN-gR2/2 mice via the
respiratory route was severe splenic atrophy.17 This ob-
servation demonstrated a novel function for this cytokine
in maintaining the splenic architecture during a gamma-
herpesvirus infection.
The most striking feature of lymphoid pathology in
IFN-gR2/2 mice is splenic atrophy coupled with exces-
sive deposition of collagen. The entire pathology is linked
to the activity of CD8 T cells, because depletion of CD8 T
cells resulted in maintenance of normal lymphoid archi-
tecture during the course of infection.17
Excessive collagen deposition in MHV-68-infected
IFN-gR2/2 mice would suggest a dysregulated cytokine
response, because overexpression of cytokines IL-4, IL-
1b, and TGF-b1, and reduced expression of interferon-g
have been shown to promote fibrosis18,19 in, for example,
systemic sclerosis20,21 and murine models of fibrosis.22,23
In the present study we have identified hitherto unre-
ported pathologies in the mediastinal lymph nodes,
lungs, and liver and have further characterized the
changes in the spleen of MHV-68-infected IFN-gR2/2
mice. Moreover, we have explored possible mechanisms
underlying spleen cell depletion and the pathological
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changes observed in these mice. Our data demonstrate
that fibrosis and loss of splenocytes observed in IFN-
gR2/2 mice are associated with inhibition of leukocyte
trafficking through the excessively fibrosed spleens of
IFN-gR2/2 mice, culminating in leukocytosis. Importantly,
a dysregulated pattern of splenic cytokines and chemo-
kines was observed in IFN-gR2/2 mice, suggesting a
possible explanation for the overt pathologies in IFN-
gR2/2 mice infected with MHV-68.
Materials and Methods
Mice
Adult wild-type (129/Sv/Ev) and IFN-gR2/2 (129/Sv/Ev)
mice were purchased from Bantin and Kingman (Hull,
UK) and bred in-house.
Virus Infection and Sampling
MHV-68 virus stocks were prepared as previously de-
scribed.4 Mice (age- and sex-matched) were anesthe-
tized with Halogen (Rhone Merieux Ltd., UK) and were
inoculated via the intranasal route with 4 3 105 plaque-
forming units of MHV-68 in 40 ml of sterile phosphate-
buffered saline. At various time intervals, mice were sac-
rificed by CO2 asphyxiation. Tissues were fixed in 10%
buffered formal saline, paraffin-embedded, and 5-mm
thick sections were stained with hematoxylin and eosin
(H&E) and Masson’s trichrome stain.
Death Assay
Terminal deoxynucleotide transferase-mediated dUTP
nick end labeling (TUNEL) was performed on paraffin-
embedded sections (in situ TUNEL) as previously de-
scribed.24
Hematology and Flow Cytometry
Venous blood (inferior vena cava, 500 ml) was collected
immediately at postmortem in EDTA tubes, stained with
monoclonal antibodies against CD4 (YTS177.9.6.1), CD8
(YTS105.18.10), and CD19 (PharMingen), and analyzed
on a FACStar Plus (Becton Dickinson) as previously de-
scribed.25 Total granulocyte counts were obtained from
fluorescence-activated cell sorter profiles.
A Baker System 9100 hematology analyzer was used
for hematological analyses. Differential white blood cell
staining was carried out on a Bayer Hematek 2000
Stainer (Department of Veterinary Clinical Studies, Clini-
cal Laboratory, Easter Bush Veterinary Center, Edin-
burgh, UK).
Leukocyte Trafficking
Peripheral blood was collected in EDTA tubes, and leu-
kocytes were obtained by density centrifugation on His-
topaque-1077 (Sigma). One milliliter of leukocytes
(108/ml in diluent C) was mixed with one ml (10 mmol/L in
diluent C) of green fluorescent dye PHK-67 (Sigma) for 6
minutes at room temperature with constant pipetting, fol-
lowed by 2 ml of fetal calf serum and 4 ml of tissue culture
medium Dulbecco’s Modified Essential (DME) to termi-
nate the labeling reaction. Labeled cells were centrifuged
at low speed (50 3 g, three minutes) and resuspended in
PBS. Each mouse was injected with 2 3 107/100 ml via
the tail vein. Three mice were injected for each time point.
After overnight injections, peripheral blood leukocytes
(PBL) and splenocytes were obtained by density centrif-
ugation. The presence of labeled cells was detected by
FACS analysis of 200,000 events per each sample. The
success of injection was based on the presence of la-
beled cells in PBL.
Ribonuclease Protection Assay
Ribonuclease protection assay (RPA) was used to quan-
titatively measure the expression of splenic cytokines and
chemokines. Spleens were snap-frozen in liquid nitrogen
immediately at postmortem and stored at 270°C before
processing. Total RNA was isolated by RNAzolB solution
(Biogenesis). Five micrograms of total RNA was hybrid-
ized to RPA probe sets: ML11 set (tumor necrosis fac-
tor-b, tumor necrosis factor-a, interleukin-4, IL-5, IL-1a,
IFN-g, IL-2, IL-6, IL-1b, IL-3, and L32), ML26 set (IL-3,
IL-10, GM-CSF, TGF-b1, IL-13, IL-12p40, IL-12p35, IL-7,
and L32), mCK5 set (LTN, RANTES, EOTAXIN, MIP-1b,
MIP-1a, MIP-2, IP-10, MCP-1, TCA-3, L32, and glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH); BD
PharMingen; 45026P), and CCR7 set (IL-4, IL-12p40,
IL-10, IL-1b, IL-13, CCR7, L32, and GAPDH; BD Phar-
Mingen; 557506). ML11 and ML26 sets were a kind gift
from Dr. M. Hobbs, Scripps Research Institute, USA. The
cloned murine monokine induced by interferon-g (MIG)
was a kind gift from Dr. M. Buchmeier (Scripps Research
Institute). RPA assays were performed according to the
RiboQuant protocol (BD PharMingen).
Bone Marrow Cellularity Measurement
Single cell suspensions of femoral bone marrow were
prepared in RPMI 1640 [10% (v/v) fetal calf serum, 2
mmol/L glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin] and cell numbers determined by hemocy-
tometry.
Cytokine Protein Assays
Splenocytes were prepared by centrifugation over Ficoll-
Hypaque (Histopaque 1077, Sigma), resuspended at 107
cells/ml in RPMI 1640 [10% (v/v) fetal calf serum, 2
mmol/L glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin] and incubated at 37°C for 24 hours.26 Su-
pernatants were then harvested for enzyme-linked immu-
nosorbent assays (ELISA). IFN-g was measured using
IFN-g antibody pair (BD PharMingen) and according to
the recommended protocol. TNF-a was assayed using
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the Quantikine M mouse TNF-a immunoassay kit (R&D
Systems).
Results
To determine whether atrophy and fibrosis were confined
to spleen and whether these changes were irreversible,
we examined spleen, lymph nodes, lungs, and other
major organs in wild-type and IFN-gR2/2 mice at intervals
up to 45 days after infection.
Histopathological Changes
The histological changes in spleens of wild-type and
IFN-gR2/2 mice were similar up to day 10, which in-
cluded germinal centers and neutrophil infiltration of si-
nusoids. An apparent increase in neutrophils was noted
in IFN-gR2/2 mice. Extensive fibrosis was detected in
spleens of IFN-gR2/2 mice by day 23 after infection (all
mice) with fibrosis in sinusoids and adjacent to germinal
centers. Furthermore, spleens of IFN-gR2/2 mice were
significantly smaller than spleens of wild-type mice [130
mg 6 26.5 (SD) versus 31 6 5.7, P , 0.05]. By day 45
after infection, spleens of IFN-gR2/2 mice appeared
more cellular compared to day 23, and showed signs of
resolving pathology. In contrast, the spleens of wild-type
mice maintained their normal architecture throughout the
course of infection (Figure 1).
The patterns of pathology in mediastinal lymph node
(MLN) were similar to the spleen in IFN-gR2/2 mice. Initial
changes (up to and including day 10) were similar in both
wild-type and IFN-gR2/2 mice (all mice), and consisted
primarily of increased numbers of blast cells. By day 14,
early fibrosis was observed in IFN-gR2/2 mice, and by day
23, MLN in IFN-gR2/2 mice showed signs of cellular deple-
tion and atrophy. However, by day 45 we observed an
increase in nodal cellularity with a partial resolution of scar-
ring (Figure 1). Importantly, the pathological changes noted
above were not observed in other secondary lymphoid tis-
sues examined. For example, both the submandibular and
the mesenteric lymph nodes in IFN-gR2/2 mice appeared
normal (data not shown).
The lymphoid tissues examined in the wild-type mice,
similar to the spleens of these mice, maintained their
normal architecture throughout the course of infection
(data not shown).
Pathological changes were also noted in lungs and
livers of IFN-gR2/2 mice infected with MHV-68. The initial
pulmonary changes were similar in both groups of mice
by day 10 after infection. These changes included inter-
stitial pneumonia and interstitial and intraalveolar fibrosis,
accompanied by pulmonary phlebitis. The pulmonary
Figure 1. Pathological changes in IFN-gR2/2 mice infected with MHV-68. Pathological changes on days 14 (I), 23 (B, E, and G), and 45 (C, F, and H) after
infection with MHV-68. A: Normal spleen before infection. B: Fibrosis in sinusoids of red pulp. C: Partial resolution of fibrosis and contraction of residual fibrous
tissue. D: Normal MLN before infection. E: Widespread fibrosis in MLN. F: Resolving fibrosis and increased cellularity in MLN. G: Periportal infiltrate encroaching
on portal vein. H: Partial resolution of hepatic changes I: Interstitial pulmonary fibrosis. Sections A and D were stained with H&E, and sections B, C, and E–I were
stained with Masson’s trichrome. Representative sections are from five mice per each time point. Original magnifications: A–F, 350; G–H, 380; I, 3250.
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changes were most severe by day 14 after infection in
IFN-gR2/2 mice and included inflammation and intersti-
tial fibrosis, accompanied by pulmonary phlebitis. The
lungs also showed signs of resolution by day 45 after
infection (Figure 1).
The hepatic changes in IFN-gR2/2 mice were appar-
ent on day 10 after infection and included multifocal
dilation of sinusoids with fibrin deposits and infiltration by
neutrophils and lymphocytes. Mild changes were ob-
served in livers of wild-type mice, which included focal
dilation of sinusoids with minor fibrin deposition and
mixed inflammatory infiltrates (data not shown).
The mild pathological changes observed in the livers
of wild-type mice were resolved by day 23 after infection
(data not shown). In contrast, the hepatic changes in
IFN-gR2/2 mice had progressed from moderate to se-
vere with extensive portal fibrosis. As with lymphoid tis-
sue changes, most of hepatic changes had resolved by
day 45 after infection (Figure 1).
Lymphoid Tissue Cellularity
To support the histological observations, we measured
the cell numbers in lymphoid tissues during the course of
infection. We found that by day 23 after infection, there
was a 120-fold reduction in spleen cell numbers in IFN-
gR2/2 mice compared to wild-type mice [9.7 3 107 6
8.1 3 105 (SD) versus 8.1 3 105 6 5.6 3 105, P , 0.05].
This reduction was followed by an increased cellularity of
spleen in IFN-gR2/2 mice evident by day 45 after infec-
tion [8.1 3 106 6 3.6 3 06 on day 45 versus 8.1 3] 105 6
5.6 3 105 on day 23, P , 0.05] (Figure 2). Similarly, the
MLN of IFN-gR2/2 mice were also depleted by day
23 after infection [3.3 3 106 6 6.4 3 105 (SD) versus 8 3
104 6 1 3 104, P , 0.05].
Our histological observations indicated an apparent
increase in neutrophils in IFN-gR2/2 mice on day 10 after
infection. This was also reflected in an increase in splenic
neutrophils in IFN-gR2/2 mice [17% 6 6.5 (SD) versus
13% 6 4.8].
Kinetics of Apoptotic Death in Spleen
The TUNEL assay was used to determine whether loss of
splenocytes in IFN-gR2/2 was due to increased apopto-
sis. The earliest TUNEL positive cells were detected on
day 4 after infection, and were located in the periarterial
lymphatic sheaths. From this point on, there was a grad-
ual increase in numbers of TUNEL positive cells, which
peaked at two weeks before a decline on day 16 after
infection (Figure 3). At the peak of splenic apoptosis, the
TUNEL positive cells were almost exclusively found within
the follicular structures. However, both the tempo and the
location of these TUNEL positive cells were similar in
wild-type and IFN-gR2/2 mice.
Hematological Changes
Lack of a substantial splenic apoptosis in IFN-gR2/2
mice suggested the possibility of altered leukocyte traf-
ficking, which could account for the loss of splenocytes in
IFN-gR2/2 mice. Therefore, we analyzed the hematolog-
ical parameters in venous blood during the course of
infection.
We found significant hematological changes in IFN-
gR2/2 mice which were apparent by day 10 after infec-
tion, where levels of circulating neutrophils were signifi-
cantly elevated in comparison to those in wild-type mice
(Figure 4).
By day 14 after infection, circulating leukocytes in IFN-
gR2/2 mice were, on average, greater than nearly three-
fold higher than those in the wild-type mice [3.3 3 107 6
1.2 3 107 (SD)/ml versus 1.3 3 107 6 5 3 106, P , 0.05]
and lymphocytes made as much as 78% of the rise in
total white blood cells (Figure 4). The elevated circulating
leukocytes in IFN-gR2/2 mice reached a maximum on
day 23 after infection [3.5 3 107 6 5.4 3 106 (SD)/ml
Figure 2. Splenic cellularity in MHV-68-infected mice. In contrast to wild-
type mice, spleens of IFN-gR2/2 mice were severely depleted by day 23 after
infection but showed signs of partial repopulation by day 45 after infection.
*, Significantly different from wild-type mice; P , 0.05. Numbers represent
mean 6 SD (n 5 3). l, wild-type mice; f, IFN-gR2/2 mice.
Figure 3. Apoptotic death in spleen. Spleens were fixed in formal saline and
stained for TUNEL. All TUNEL-positive cells were counted on each section.
Numbers of TUNEL-positive cells were comparable between IFN-gR2/2 and
wild-type mice during the course of infection. Numbers represent mean 6
SD. l, wild-type mice; f, IFN-gR2/2 mice.
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versus 1.1 3 107 6 5.4 3 106, P , 0.05]. Again, lympho-
cytes constituted the major population (89%) of circulat-
ing leukocytes (Figure 4).
The hematological changes observed at earlier time
points in IFN-gR2/2 mice were resolved on day 45 after
infection (Figure 4). At this late time point, the levels of
circulating leukocytes in IFN-gR2/2 mice were more than
halved when compared to day 14, and were in the same
range as circulating leukocytes in wild-type mice [1.6 3
107 6 5.3 3 106 (SD)/ml versus 1.4 3 107 6 5 3 106]
(Figure 4). These reductions in total venous blood leuko-
cytes were similar to reductions in total lymphocyte levels
[1.4 3 107 6 5 3 106 (SD)/ml versus 1.2 3 107 6 4.3 3
106]. Notably, the resolution of leukocytosis also coin-
cided with significant histological changes in spleens of
IFN-gR2/2 mice (Figure 1).
We found no preferential expansion of any lymphocyte
subset during leukocytosis. Moreover, the percentages
of venous blood T (CD4 and CD8) and B (CD19) lympho-
cytes were similar between both wild-type and IFN-gR2/2
mice (data not shown). We also analyzed the femoral
bone marrow cellularity in wild-type and IFN-gR2/2 mice.
Bone marrow cellularity was comparable between wild-
type and IFN-gR2/2 mice during the entire course of
MHV-68 infection (data not shown).
Leukocyte Trafficking during MHV-68 Infection
To address the cause of leukocytosis, PBL from wild-type
and IFN-gR2/2 mice were labeled with the green fluores-
cent dye, PKH-67, and used in cross transfer studies.
PBL from IFN-gR2/2 mice (day 23 after infection) were
able to traffic through the spleen of wild-type mice (day
23 after infection), but not through the spleens of IFN-
gR2/2 mice on day 23 after infection (but did traffic
through the spleens of these mice on day 10 after infec-
tion) (Figure 5). These data clearly show that an inhibition
in cell trafficking between spleen and blood is a major
cause of leukocytosis in IFN-gR2/2 mice.
Splenic Cytokine and Chemokine Changes
Multiprobe RPA sets and ELISA assays were used to
analyze the levels of cytokines and chemokines, which
may play a role in the pathologies observed in spleens of
IFN-gR2/2 mice.
The splenic mRNA levels of IFN-g were significantly
higher in IFN-gR2/2 mice than in wild-type mice, reach-
ing a peak on day 14 after infection [0.397 OD 6 0.018
(SD) versus 0.075 6 0.018, P , 0.05]. Similarly, levels of
TNF-a [0.683 OD 6 0.05 (SD) 0.3596 6 0.06, P , 0.05],
TNFb [0.71 OD 6 0.17 (SD) versus 0.42 6 0.12, P ,
0.05], IL-1b [0.38 6 0.03 OD (SD) versus 0.062 6 0.01,
Figure 4. Hematological changes in MHV-68-infected mice. Venous blood was
analyzed before infection and throughout the course of infection with MHV-68
BI. l, wild-type mice; f, IFN-gR2/2 mice; *, significantly elevated in IFN-
gR2/2 mice; P , 0.05. Numbers represent mean 6 SD (n 5 5).
Figure 5. Inhibition of leukocyte trafficking through the severely fibrosed
spleens. FACS analyses of splenocytes from (A) wild-type mice on day 23
after infection, (B) IFN-gR2/2 mice on day 23 after infection, and (C)
IFN-gR2/2 mice on day 10 after infection injected 24 hours previously with
labeled PBL from IFN-gR2/2 mice after 23 days after infection. Data are
representatives of three mice per each group.
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P , 0.05], and TGF-b1 [3.17 6 0.28 OD (SD) versus
2.44 6 0.23, P , 0.05] were significantly elevated on day
14 after infection in spleens of IFN-gR2/2 mice compared
to the wild-type mice (Figure 6).
The IFN-g protein concentrations in splenocyte cul-
tures from infected mice complemented the RPA data for
this cytokine [32.075 6 4.822 (SD) ng/ml versus 0.345 6
0.466, P , 0.05]. Similarly, a TNF-a-specific ELISA was
used to measure the protein concentration of this cyto-
kine in splenocyte cultures obtained from infected mice.
The splenic TNF-a protein levels were on average 2.8-
fold higher in IFN-gR2/2 mice on day 14 after infection
than in wild-type mice [0.536 6 0.16 (SD) ng/ml versus
0.187 6 0.057, P , 0.05] (Table 1).
In contrast to above, IP-10 was elevated in wild-type
mice on day 14 after infection [0.322 6 0.0432 (SD) OD
versus 0.1033 6 0.0163, P , 0.05] (Figure 6). Similarly,
whereas the mRNA for MIG was readily detected in wild-
type mice, we did not detect the transcript for this che-
mokine in IFN-gR2/2 mice (data not shown).
RANTES was abundantly expressed in both wild-type
and IFN-gR2/2 mice. Interestingly, the elevated levels of
this chemokine were sustained even at late time points
when there was a reduction in other mRNA species stud-
ied (Figure 6).
Figure 6. Splenic expression of cytokines and chemokines in MHV-68-
infected mice. Gene-specific multiprobe RPA sets were used to measure the
levels of splenic cytokines and chemokines. Representative autoradiographs:
A, ML11 set (7 day exposure); B, CCR7 set (7 day exposure); C, ML26 set
(overnight exposure to show elevated expression of TGF-b1 in IFN-gR2/2
mice); D, mCK5 set (14 day exposure to show elevated levels of LTN in
IFN-gR2/2 mice); E, Significant fold changes in spleens of IFN-gR2/2 mice
compared to wild-type mice on day 14 after infection. Data were obtained
from five mice per group per each time point. Mean ratios of optical density
(633 nm) of cytokine/chemokine mRNA levels were calculated against the
mean signals for housekeeping genes, L32, and GAPDH.
Table 1. Cytokine Protein Concentrations in Splenocyte
Cultures from MHV-68-Infected Mice
Day IFN-gR1/1 IFN-gR2/2
IFN-g 10 3860 (3931) 12992 (66060)
14 345 (465) 32075 (64821)*
TNF-a 10 276 (125) 273 (682)
14 187 (57) 536 (6159)*
Protein levels (pg/ml) were measured in supernatants of splenocytes
cultured in vitro from MHV-68-infected mice. Note that in contrast to day
10, the levels of both cytokines were significantly elevated on day 14 in
IFN-gR2/2 mice.
* Statistically elevated in IFN-gR2/2 mice; P , 0.05. Numbers
represent mean 6 SD (n 5 4).
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MIP1b levels were on average threefold higher on day
14 after infection in spleens of IFN-gR2/2 mice than in
wild-type mice [0.15 6 0.08 (SD) versus 0.048 6 0.02,
P , 0.05] (Figure 6).
The basal levels of the chemokine lymphotactin were
similar in both wild-type and IFN-gR2/2 mice. However,
the levels of this chemokine reached a peak on day 14
after infection and were significantly higher in IFN-gR2/2
mice than in wild-type mice (0.12 6 0.04 (SD) versus
0.07 6 0.02, P , 0.05), before subsiding to pre-infection
levels by day 45 after infection (Figure 6).
Discussion
Our findings show that MHV-68 infection of IFN-gR2/2
mice results in fibrosis and atrophy of the spleen and
MLN with severe cellular depletion of these organs cul-
minating in leukocytosis. The pathologies in IFN-gR2/2
mice include extensive mononuclear cell infiltration of the
lung and the liver, with pulmonary interstitial fibrosis and
hepatic portal fibrosis, respectively. The fibrosis and leu-
kocytosis in IFN-gR2/2 mice are associated with elevated
levels of pro-fibrotic cytokines and a dysregulated che-
mokine response. These pathologies showed signs of
resolution by day 45 after infection.
A prominent feature of splenic pathology in infected
IFN-gR2/2 mice is loss of splenocytes. Despite elevated
levels of TNF-a and TNF-b in spleens of IFN-gR2/2 mice,
we found no significant increase in splenic apoptosis or
changes in bone marrow cellularity to account for the
reduced spleen cell numbers in these mice.
Our present work shows that the loss of splenic cellu-
larity coincides with a dramatic increase in the number of
T and B lymphocytes in peripheral blood. This is in agree-
ment with our previous observation, in which T and B
lymphocytes were lost from the spleens of IFN-gR2/2
mice.17 Furthermore, we found no particular increase in
CD8 T cells during leukocytosis as observed in infectious
mononucleosis seen in EBV and MHV-68.5
The increases in PBL in IFN-gR2/2 mice were directly
related to splenic atrophy, ie, the most depleted spleens
had the highest levels of circulating leukocytes. This leu-
kocytosis results, in part, from inhibited trafficking of pe-
ripheral blood cells through the fibrosed spleens of IFN-
gR2/2 mice. PBL taken from IFN-gR2/2 mice at the
height of leukocytosis (day 23) did not traffic through the
spleens of IFN-gR2/2 mice on day 23 after infection (ie, at
the peak of leukocytosis), but were able to traffic through
the spleens of wild-type mice synchronously infected with
MHV-68 and also entered the spleens of IFN-gR2/2 mice
on day 10 after infection, ie, before extensive deposition
of extracellular matrix.
We found that levels of IL-1b, TNF-a, TNF-b, TGF-b1,
and IFN-g were significantly elevated in spleens of IFN-
gR2/2 mice. Similar cytokine imbalances have also been
associated with several human diseases with fibrosis and
in murine models of fibrosis.20–23 Of these cytokines,
TNF-a, TGF-b1, and IL-1b are potent inducers of fibro-
sis,27–28 whereas IFN-g is a potent anti-fibrogenic cyto-
kine and down-regulates the expression of both type I
and type III collagens and fibronectin.29–32 Conse-
quently, lack of IFN-g-mediated responses in IFN-gR2/2
mice together with elevated levels of fibrogenic cytokines
would further support a dysregulated cytokine response
as a cause of fibrosis in IFN-gR2/2 mice. Interestingly, a
reduced trend in the expression of these cytokines coin-
cided with a partial resolution of the pathologies by day
45 after infection. Moreover, despite the absence of a
functional IFN-g system, the cytokines IL-4 and IL-10,
associated with Th2 responses were not upregulated in
IFN-gR2/2 mice.
The inhibited trafficking of leukocytes through the
spleens of IFN-gR2/2 mice prompted an analysis of
chemokines, because they play a crucial role in leuko-
cyte trafficking.33 CXC chemokines IP-10 and MIG
were significantly elevated in wild-type mice and are
involved in the recruitment of T cells via the CXCR3
receptor.34 Elevated levels of IP-10 and MIG were ob-
served on day 14 after infection in infected wild-type
mice (at the peak of splenomegaly), but were signifi-
cantly reduced in the spleen of infected IFN-gR2/2
mice (which lacked splenomegaly), further supporting
previous observations on requirement of a functional
IFN-g for induction of these chemokines.35 IP-10 has
been shown to inhibit fibroplasia and deposition of
extracellular matrix proteins,36 and so a reduction in
the expression of this chemokine and MIG during in-
fection must affect splenic pathology.
MIP-1b and LTN are potent chemoattractants.37 Par-
adoxically, spleens of IFN-gR2/2 mice showed ele-
vated levels of MIP-1b and LTN compared to wild-type
mice. However, elevated levels of cytokines, for exam-
ple TNFa, can inhibit cell migration by down-regulating
chemokine receptors.38 Therefore, a similar inhibitory
mechanism may provide an explanation for the elevated
levels of MIP-1b and LTN despite cellular depletion in IFN-
gR2/2 mice.
The pathologies associated with MHV-68 infection of
IFN-g2/2 mice may have important implications for hu-
man fibrotic conditions. Of significance here is the idio-
pathic pulmonary fibrosis (or cryptogenic fibrosing alve-
olitis), which is an immune-mediated disorder and has
been associated with EBV infection.39 Furthermore, sev-
eral familial genetic defects associated with disruption of
the IFN-gR have been reported in man.40 Although no
clinical viral disease has yet been identified in these
patients, it is conceivable that a similar fate may ensue
after infection with EBV or Kaposi’s sarcoma-associated
herpesvirus.
In conclusion, we demonstrated that MHV-68 ini-
tiates a cascade of pathological events in IFN-gR2/2
mice. The expulsion of cells from the spleen leads to a
rise in leukocytes in the peripheral blood. These cells
are unable to re-enter the spleen despite, or because
of, the elevated levels of inflammatory cytokines in the
spleen. Tissue remodeling occurs, and there is a re-
population of the affected lymphoid tissues. Whereas
data in this report may explain the likely molecular
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basis for fibrosis, further work is needed to determine
how MHV-68 gene expression alters the pattern of
cytokines and chemokines in IFN-gR2/2 mice and to
understand the role of CD8 T cells in mediating this
process.
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